Journal of Cancer Education

, Volume 27, Issue 1, pp 105–111

Important Considerations for Recruiting Women to Cancer Genetics Studies in Puerto Rico

  • Euna M. August
  • Gwen P. Quinn
  • Rossybelle Perales
  • Zuheily Closser
  • Julie Dutil
  • Marieva Puig
  • Susan T. Vadaparampil


A goal of the Minority Institution/Cancer Center Partnership between the Ponce School of Medicine in Puerto Rico and the H. Lee Moffitt Cancer Center & Research Institute in Florida is to provide cross-cultural training in cancer research. This is achieved through a collaborative summer exchange program, which provides US students with an opportunity to conduct research in Puerto Rico. As part of this program, students recruited participants and collected data for a study to enhance the understanding of sociocultural factors among Puerto Rican women regarding genetic testing for hereditary breast/ovarian cancer. Limited studies have examined cancer genetics issues among Latinos, particularly those specific to the various Latino subgroups, such as Puerto Ricans. As a result of the student training experience, culturally appropriate strategies for the recruitment of women in Puerto Rico have been identified. These recommendations can inform the design of cancer research projects and interventions targeting the Puerto Rican population.


Cross-cultural research Underserved populations Puerto Rico Latino health Breast cancer Genetic testing for cancer 


  1. 1.
    Gonzalez-Burchard E, Borrell LN, Choudhry S, Naqvi M, Tsai H, Rodriguez-Santana JR, Chapela R et al (2005) Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. American Journal of Public Health 95:2161–2168PubMedCrossRefGoogle Scholar
  2. 2.
    Solomon FM, Eberl-Lefko AC, Michaels M, Macario E, Tesauro G, Rowland JH (2005) Development of a linguistically and culturally appropriate booklet for Latino cancer survivors: lessons learned. Heal Promot Pract 6(4):405–413CrossRefGoogle Scholar
  3. 3.
    Pinheiro PS, Sherman RL, Trapido EJ, Fleming LE, Huang Y, Gomez-Marin O, Lee D (2009) Cancer incidence in first generation US Hispanics: Cubans, Mexicans, Puerto Ricans, and New Latinos. Cancer Epidemiology, Biomarkers & Prevention 18(8):2162–2169CrossRefGoogle Scholar
  4. 4.
    Puerto Rico USA Citizenship Foundation (1998) View of Congress, the Courts and the Federal Government. Accessed 14 Feb 2011.
  5. 5.
    Torres MI, Marquez DX, Carbone ET, Stacciarini JR, Foster JW (2008) Culturally responsive health promotion in Puerto Rican communities: a structuralist approach. Heal Promot Pract 9(2):149–158CrossRefGoogle Scholar
  6. 6.
    American Cancer Society (2010) Cancer facts & figures for Hispanics/Latinos 2009–2011. Accessed 23 Jun 2010.
  7. 7.
    Puerto Rico Central Cancer Registry (2008) Stat fact sheet: cancer of the breast. Accessed 22 Jun 2010.
  8. 8.
    Mullineaux LG, Castellano TM, Shaw J, Axell L, Wood ME, Diab S et al (2003) Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Cancer 98(3):597–602PubMedCrossRefGoogle Scholar
  9. 9.
    Weitzel JN, Lagos V, Blazer KR, Nelson R, Ricker C, Herzog J et al (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14(7):1666–1671PubMedCrossRefGoogle Scholar
  10. 10.
    Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, Ho JS et al (2007) Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 16(8):1615–1620PubMedCrossRefGoogle Scholar
  11. 11.
    Carter RF (2001) BRCA1, BRCA2 and breast cancer: a concise clinical review. Clin Invest Med 24(3):147–157PubMedGoogle Scholar
  12. 12.
    MacDonald DJ, Choi J, Ferrell B, Sand S, McCaffrey S, Blazer KR et al (2002) Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment. J Med Genet 39(7):526–530PubMedCrossRefGoogle Scholar
  13. 13.
    Robson ME, Boyd J, Borgen PI, Cody HS (2001) Hereditary breast cancer. Curr Probl Surg 38(6):387–480PubMedCrossRefGoogle Scholar
  14. 14.
    Tonin PN (2000) Genes implicated in hereditary breast cancer syndromes. Semin Surg Oncol 18(4):281–286PubMedCrossRefGoogle Scholar
  15. 15.
    Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, van Geel AN (1998) Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351(9099):316–321PubMedCrossRefGoogle Scholar
  16. 16.
    Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343(8899):692–695PubMedCrossRefGoogle Scholar
  17. 17.
    Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328–2335PubMedCrossRefGoogle Scholar
  18. 18.
    Robson M, Svahn T, McCormick B, Borgen P, Hudis CA, Norton L et al (2005) Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer 103(1):44–51PubMedCrossRefGoogle Scholar
  19. 19.
    John EM, Miron A, Gong G, Phipps AI, Felberg A, Frederick P et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298(24):2869–2876PubMedCrossRefGoogle Scholar
  20. 20.
    Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84PubMedCrossRefGoogle Scholar
  21. 21.
    Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633–1637PubMedCrossRefGoogle Scholar
  22. 22.
    Meijers-Heijboer EJ, Verhoog L, Brekelmans C, van Geel CA, Seynaeve C, van den Ouweland A et al (1999) Bilateral prophylactic mastectomy in BRCA1/2 mutation carriers: predictive factors and follow-up. Am J Hum Genet 65:A22Google Scholar
  23. 23.
    Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van’t Veer L, Garber JE et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062PubMedCrossRefGoogle Scholar
  24. 24.
    Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M et al (2006) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118(9):2281–2284PubMedCrossRefGoogle Scholar
  25. 25.
    Chen WY, Garber JE, Higham S, Schneider KA, Davis KB, Deffenbaugh AM et al (2002) BRCA1/2 genetic testing in the community setting. J Clin Oncol 20(22):4485–4492PubMedCrossRefGoogle Scholar
  26. 26.
    Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh M, Frye C et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115(10):2222–2233PubMedCrossRefGoogle Scholar
  27. 27.
    Ricker C, Lagos V, Feldman N, Hiyama S, Fuentes S, Kumar V et al (2006) If we build it … will they come?—establishing a cancer genetics services clinic for an underserved predominantly Latina cohort. J Genet Couns 15(6):505–514PubMedCrossRefGoogle Scholar
  28. 28.
    Penchaszadeh VB (2001) Genetic counseling issues in Latinos. Genet Test 5(3):193–200PubMedCrossRefGoogle Scholar
  29. 29.
    Ramirez, A. G (2003) Hispanic/Latino Genetics Community Consultation Network (HLGCCN) Summit Report 2003. San Antonio, TX: Redes En Accion Accessed 30 Jun 2010.
  30. 30.
    Doksum T, Joseph C, Watson M, Leighna Kim SM, Brand A (2004) Genetics education and underserved populations: summary of the literature. Abt Associates, Inc., CambridgeGoogle Scholar
  31. 31.
    Vadaparampil ST, McIntyre J, Quinn GP (2010) Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity. J Genet Couns 19(6):618–629PubMedCrossRefGoogle Scholar
  32. 32.
    Ramirez AG, Aparicio-Ting FE, de Majors SS, Miller AR (2006) Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors. Ethn Dis 16(2):398–403PubMedGoogle Scholar
  33. 33.
    Lacour RA, Daniels MS, Westin SN, Meyer LA, Burke CC, Burns KA et al (2008) What women with ovarian cancer think and know about genetic testing. Gynecol Oncol 111(1):132–136PubMedCrossRefGoogle Scholar
  34. 34.
    Vadaparampil ST, Wideroff L, Breen N, Trapido E (2006) The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey. Cancer Epidemiology, Biomarkers & Prevention 15(4):618–623CrossRefGoogle Scholar
  35. 35.
    Kinney AY, Gammon A, Coxworth J, Simonsen SE, Arce-Laretta M (2010) Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet Med 12(2):105–115PubMedCrossRefGoogle Scholar
  36. 36.
    Quinn GP, McIntyre J, Vadaparampil ST (2011) Preferences for hereditary breast and ovarian cancer information among Mexican, Cuban and Puerto Rican women at risk. Public Health Genomics 14:248–258PubMedCrossRefGoogle Scholar
  37. 37.
    Vadaparampil ST, Quinn GP, Small BJ, McIntyre J, Loi CA, Closser Z, Gwede CK (2010) A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancer. Genetic Testing and Molecular Biomarkers 14(1):99–106PubMedCrossRefGoogle Scholar
  38. 38.
    Larkey LK, Gonzalez JA, Mar LE, Glantz N (2009) Latina recruitment for cancer prevention education via Community Based Participatory Research strategies. Contemp Clin Trials 30(1):47–54PubMedCrossRefGoogle Scholar
  39. 39.
    Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726PubMedCrossRefGoogle Scholar
  40. 40.
    Ramirez AG, Talavera GA, Marti J, Penedo FJ, Medrano MA, Giachello AL (2006) Redes En Acción. Increasing Hispanic participation in cancer research, training, and awareness. Cancer 107(8):2023–2033PubMedCrossRefGoogle Scholar
  41. 41.
    Yancey AK, Ortega AN, Kumanyika SK (2006) Effective recruitment and retention of minority research participants. Annu Rev Public Health 27:1–28PubMedCrossRefGoogle Scholar
  42. 42.
    Sheppard VB, Cox LS, Kanamori MJ, Cañar J, Rodríguez Y, Goodman M et al (2005) Brief report: if you build it, they will come: methods for recruiting Latinos into cancer research. J Gen Intern Med 20(5):444–447PubMedCrossRefGoogle Scholar
  43. 43.
    Lange JW (2002) Methodological concerns for non-Hispanic investigators conducting research with Hispanic Americans. Res Nurs Health 25(5):411–419PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Euna M. August
    • 1
    • 2
  • Gwen P. Quinn
    • 1
  • Rossybelle Perales
    • 1
  • Zuheily Closser
    • 3
  • Julie Dutil
    • 4
  • Marieva Puig
    • 5
  • Susan T. Vadaparampil
    • 1
  1. 1.Health Outcomes & Behavior ProgramH. Lee Moffitt Cancer Center & Research InstituteTampaUSA
  2. 2.College of Public Health, Department of Community & Family HealthUniversity of South FloridaTampaUSA
  3. 3.University of South Florida, College of MedicineTampaUSA
  4. 4.Department of BiochemistryPonce School of MedicinePonceUSA
  5. 5.University of Puerto RicoBayamonUSA

Personalised recommendations